Login / Signup

The efficacy and safety of esketamine in the treatment of major depressive disorder with suicidal ideation: study protocol for a randomized controlled trial.

Haiyan LiuXiaofeng LanChengyu WangFan ZhangLing FuWeicheng LiYanxiang YeZhibo HuZiyuan ChaoYuping NingYanling Zhou
Published in: BMC psychiatry (2022)
Chinese Clinical Trial Register, ChiCTR2000041232 . Registered 22 December 2020.
Keyphrases
  • major depressive disorder
  • clinical trial
  • bipolar disorder
  • randomized controlled trial
  • open label
  • study protocol
  • phase ii
  • combination therapy